about
Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patientsAntithrombotic therapy in patients with chronic kidney diseaseLessons from the GHOST-EU registryLeft ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study.Cardiovascular magnetic resonance for the assessment of patients undergoing transcatheter aortic valve implantation: a pilot study.Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United States.Percutaneous mitral valve repair with the MitraClip system: acute results from a real world settingPercutaneous coronary intervention versus coronary artery bypass graft surgery in left main coronary artery disease: a meta-analysis of randomized clinical data.Meta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterization.Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary intervention.Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients.Properties and clinical development of a novel coating technology: the poly[bis(trifluoroethoxy)phosphazene].Platelet thrombin receptor antagonism and atherothrombosisTranscatheter aortic valve implantation: what has been done and what is going to be done.Mechanism of action and clinical development of ticagrelor, a novel platelet ADP P2Y12 receptor antagonist.Clinical development of selective anticoagulants: a state of the art.Antithrombotic therapy in the elderly.The optimal pharmacological formula for percutaneous coronary intervention.Novel drug-eluting stents in the treatment of de novo coronary lesions.Are propensity scores really superior to standard multivariable analysis?A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention.Novel drugs for oral anticoagulation pharmacotherapy.Facilitated/pharmaco-invasive approaches in STEMI.Percutaneous recanalization of chronic total occlusions: wherein lies the body of proof?Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature.Antiplatelet therapy: new pharmacological agents and changing paradigms.Updating the evidence on patent foramen ovale closure versus medical therapy in patients with cryptogenic stroke: a systematic review and comprehensive meta-analysis of 2,303 patients from three randomised trials and 2,231 patients from 11 observatiBridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside.Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery.Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition.Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions.Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies.Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working GroUpdates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes.A multidisciplinary consensus document on follow-up strategies for patients treated with percutaneous coronary intervention.Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients.Pretreatment with antiplatelet drugs in invasively managed patients with coronary artery disease in the contemporary era: review of the evidence and practice guidelines.Current status and clinical development of transcatheter approaches for severe mitral regurgitation.Pharmacodynamic evaluation of pantoprazole therapy on clopidogrel effects: results of a prospective, randomized, crossover study.
P50
Q26780172-EE5035B5-036F-42E9-BA31-789D8AA3E643Q26864047-3CECA05E-0037-4E7D-BAB3-6B79438D438AQ28083187-5F989E7D-0D89-4B37-B764-E86B6BBA7CB7Q30453765-F2CC6409-7DC2-4912-BC42-ABE1C2682328Q30470760-71FCA9E5-27CF-4B9E-90C7-B973BD8C8AD9Q30838830-3007CD99-2D5E-4667-9DB7-785E2CA7C51BQ33886901-72CC8591-2CC3-479D-A9DB-1B6130E87442Q34028021-F57D25B4-1C1F-4881-8EE0-E869A29BF9D1Q35202610-AC7E8163-91E3-4284-8C7F-341527B8AC78Q35583879-837A8759-656F-4F04-9A3A-CBDD399C659BQ35694086-D36707B9-350D-489E-B1A7-2F4EEA63C82BQ37638773-8BA85154-CF7A-4D52-8568-DC9ECDC0E0A6Q37641556-DA45E776-11F5-4413-BD0A-B7A46943B5E1Q37656342-282C1BBA-B454-4FB1-A6DE-5DBBF0341D25Q37688144-4F6E4D37-F28B-43FA-BC7A-E62D4C22B2ADQ37701891-FC864FAD-6795-4493-8C75-505F009B27CDQ37808801-89B02729-1480-4337-97CB-B76F07A003F8Q37830053-63B56E80-5E4C-4B59-B500-609B239B6B87Q37854458-784AEEF3-F809-4ABC-B2DD-3B7CBBB32C93Q37880361-ABCEF393-1AB8-4546-8F5A-CC8846C6F2EBQ37932112-FB3DC461-FFE1-4A01-8E0E-3CBD3EE9A791Q37998113-7F38F7ED-E5BC-4542-8AE3-1CCF2B9063F2Q38037668-7E0FD745-03ED-4F25-BDCE-3C2763533DF0Q38076852-243EB3D1-812F-4974-B0CD-E1C974D1BC3FQ38087381-8CCE1B62-1090-429D-90E4-01A680772633Q38090308-AF3B9801-5105-40ED-BD58-5E5A2BBA5601Q38117743-D2E43A59-7955-4549-91A0-5C64093912DFQ38163307-4533DFE9-ED05-461B-92FF-434A30E6CC13Q38165873-F8A49C92-F29D-4F36-9328-0733C3A4859DQ38173697-0F57226C-1431-41D1-BF9B-85EBBA02191EQ38188329-8BC30F74-7167-49E3-9721-5769443F1234Q38189334-E092C5DE-CA13-4CB6-9D79-B0A886726607Q38212120-F7145B06-6324-4E88-B366-D3B2BECD28FEQ38242976-D165B13D-5E4A-4FF9-83AA-5A689D304A35Q38249105-AA92E00A-5D7D-4F00-9581-A395F995E2A8Q38266148-98A85819-8C11-4DBF-B2AB-5C1E188437DCQ38344419-370D7F8D-89FD-4937-B7DF-486D0CBF95E6Q38365363-A03390D7-3ABD-4F4A-8031-FE8AD000B1C0Q38462564-FB70CE90-44DA-4E2E-91FF-B8F4D7C52657Q38491857-F3AC0C0A-57D3-4715-BDE5-F410EBA05498
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Davide Capodanno
@ast
Davide Capodanno
@en
Davide Capodanno
@es
Davide Capodanno
@nl
Davide Capodanno
@sl
type
label
Davide Capodanno
@ast
Davide Capodanno
@en
Davide Capodanno
@es
Davide Capodanno
@nl
Davide Capodanno
@sl
prefLabel
Davide Capodanno
@ast
Davide Capodanno
@en
Davide Capodanno
@es
Davide Capodanno
@nl
Davide Capodanno
@sl
P1006
P214
P244
P1006
P106
P1153
25642544700
P21
P213
0000 0001 0587 8363
P214
P244
no2010150816
P31
P496
0000-0002-5156-7723
P734
P735
P7859
lccn-no2010150816